Baolingbao Biology Co.,Ltd. (SHE:002286)

Baolingbao Biology Revenue

Baolingbao Biology had revenue of 760.09M CNY in the quarter ending September 30, 2026, with 4.53% growth. This brings the company's total for the last twelve months to 2.88B, up 6.91% year-over-year. In the year 2025, Baolingbao Biology had annual revenue of 2.75B with 14.54% growth. That makes Baolingbao Biology the 12,134th largest company in the world by revenue and 2,094th in China.

• Revenue (ttm): 2.88B
• Revenue Growth: +6.91%
• P/S Ratio: 1.18
• Revenue / Employee: 1.91M
• Employees: 1,505
• Market Cap: 3.40B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 2.03B 73.8%
• Foreign 719.52M 26.2%

Fiscal year ended Dec 31, 2025 See the full Baolingbao Biology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.75B	349.27M	14.54%
Dec 31, 2024	2.40B	-122.16M	-4.84%
Dec 31, 2023	2.52B	-188.83M	-6.96%
Jan 1, 2023	2.71B	-52.23M	-1.89%
Jan 1, 2022	2.76B	710.40M	34.58%

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error